ArticleScientific reports2022
Modeling the spatio‑temporal spread of COVID‑19 cases, recoveries and deaths and effects of partial and full vaccination coverage in Canada.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purposes of our study are to map high-risk areas in Canada as well as quantifying the effects of vaccination intervention and socio-demographic factors on the transmission rates of infection, recovery, and death related to COVID-19. The data of this research included weekly number of COVID‑19 cases, recovered, and dead individuals from 2020 through 2021 in Canada at health region and provincial levels. These data were associated with cumulative rates of partial and full vaccination and socio-demographic factors. We applied the spatio-temporal Susceptible-Exposed-Infected-Removed (SEIR), and Susceptible-Exposed-Infected-Removed-Vaccinated (SEIRV) models. The results indicated the partial vaccination rate has a greater effect compared with full vaccination rate on decreasing the rate of infectious cases (risk ratio (RR) = 0.18; 95%CrI: 0.16-0.2; RR = 0.60; 95%CrI: 0.55-0.65, respectively) and increasing the rate of recovered cases (RR = 1.39; 95%CrI: 1.28-1.51; RR = 1.21; 95%CrI: 1.23-1.29, respectively). However, for mortality risk reduction, only increasing full vaccination rate was significantly associated (RR = 0.09; 95%CrI: 0.05-0.14). In addition, our results showed that regions with higher rates of elderly and aboriginal individuals, higher population density, and lower socioeconomic status (SES) contribute more to the risk of infection transmission. Rates of elderly and aboriginal individuals and SES of regions were significantly associated with recovery rate. However, elderly individuals rate of regions was only a significant predictor of mortality risk. Based on the results, protection against mild and severe COVID-19 infection after the primary vaccination series decreased.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.